(CEL) |
| 0 (0%) 07-16 12:35 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 336.73 |
| Resistance 1: | 288.30 |
| Pivot price: | 277.20 |
| Support 1: | 267.35 |
| Support 2: | 254.40 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 7.380 |
| Book Value | 35.550 |
| PEG Ratio | 2.55 |
| Gross Profit | 25.938 |
| Profit Margin (%) | 12.80 |
| Operating Margin (%) | 16.93 |
| Return on Assets (ttm) | 8.0 |
| Return on Equity (ttm) | 22.4 |
Company news
Thu, 16 Jul 2026
Videos: Cel Ray: "Teen (Cult) Song" - Punknews.org
Wed, 15 Jul 2026
The Racoons: Every cel was drawn, coloured by hand - The Kingston Whig Standard
Wed, 15 Jul 2026
Cel Ray - "Teen (Cult) Song" (Official Music Video) - YouTube
Wed, 15 Jul 2026
TABLE-CEL -Q1 group results - TradingView
Mon, 13 Jul 2026
CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine® to Market for Newly Diagnosed Head and Neck Cancer - BioSpace
Mon, 13 Jul 2026
Cancer drug Multikine heads into 212-patient global trial for head and neck tumors - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
